C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
3.925
-0.125 (-3.08%)
Nov 21, 2024, 2:59 PM EST - Market open

C4 Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for C4 Therapeutics stock have an average target of 10, with a low estimate of 4.00 and a high estimate of 20. The average target predicts an increase of 154.78% from the current stock price of 3.93.

Analyst Consensus: Buy
Target Low Average Median High
Price $4.00 $10 $8.00 $20
Change +1.91% +154.78% +103.82% +409.55%

Analyst Ratings

The average analyst rating for CCCC stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 222221
Buy 221111
Hold 444444
Sell 000000
Strong Sell 000000
Total 887776

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Stephens & Co.
Stephens & Co.
Hold
Initiates
$4
Hold Initiates $4 +1.91% Nov 18, 2024
BMO Capital
BMO Capital
Buy
Reiterates
$20
Buy Reiterates $20 +409.55% Aug 6, 2024
Wells Fargo
Wells Fargo
Hold
Maintains
$7$8
Hold Maintains $7$8 +103.82% May 9, 2024
Stifel
Stifel
Strong Buy
Maintains
$13$14
Strong Buy Maintains $13$14 +256.69% May 9, 2024
Morgan Stanley
Morgan Stanley
Hold
Maintains
$1$8
Hold Maintains $1$8 +103.82% Feb 26, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
36.69M
from 20.76M
Increased by 76.74%
Revenue Next Year
16.37M
from 36.69M
Decreased by -55.37%
EPS This Year
-1.54
from -2.67
EPS Next Year
-1.75
from -1.54
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
21.38M33.20M45.79M31.10M20.76M36.69M16.37M17.71M
Revenue Growth
10.42%55.25%37.93%-32.08%-33.25%76.74%-55.37%8.15%
EPS
-31.03-5.83-1.82-2.62-2.67-1.54-1.75-1.65
EPS Growth
--------
Forward PE
--------
No. Analysts -----10108
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 42.4M 31.5M 38.6M
Avg 36.7M 16.4M 17.7M
Low 29.4M n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High
104.4%
-14.1%
136.0%
Avg
76.7%
-55.4%
8.1%
Low
41.6%
- -

EPS Forecast

EPS 202420252026
High -1.51 -1.48 -1.40
Avg -1.54 -1.75 -1.65
Low -1.58 -1.86 -2.20

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.